Litigation Details for IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)

IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)

Docket		Date Filed	2017-12-20
Court	District Court, D. New Jersey	Date Terminated	2020-05-19
Cause	15:1126 Patent Infringement	Assigned To	Stanley R. Chesler
Jury Demand	None	Referred To	Cathy L. Waldor
Patents	7,094,427; 8,377,474; 8,454,998; 8,557,283; 9,089,607; 9,089,608
Link to Docket	External link to docket

Details for IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
2017-12-20	1		and legally issued United States Patent No. 9,089,608 (“the ’608 patent”) entitled “Controlled Release …prior to the expiration of United States Patent No. 9,089,608. … U.S. Patent No. 9,089,608 On June 28, 2015, the PTO…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…term of the ’608 patent would further infringe at least claim 21 of the ’608 patent under 35 U.S.C.	External link to document
2018-11-28	103		of equivalents, any valid claim of U.S. Patent Nos. 7,094,427; 8,377,474; 8,454,998; 8,557,283; and 9,… 2017 19 May 2020 2:17-cv-13476 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-07-25	145		component” in various claims in U.S. Patent No. 8,377,474 (the “’474 patent”) and found that, during prosecution…collectively, “Zydus”). In this patent infringement suit involving a pharmaceutical patent, the parties seek construction…construction of a claim term in U.S. Patent No. 9,089,608 (“the ’608 patent”). The parties dispute … attaches to the patent and then spreads to every limb and leaf in the family patent tree. It is not …prosecution of the ‘474 patent, cannot, 1 Zydus claims that the claims in the ‘474 patent also contained	External link to document